Literature DB >> 8043530

Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.

M C Waldo1, E Cawthra, L E Adler, S Dubester, M Staunton, H Nagamoto, N Baker, A Madison, J Simon, A Scherzinger.   

Abstract

Schizophrenia may result from the concerted action of several pathophysiological factors. This pilot study compared the distribution of measurements of three such putative factors in 11 schizophrenics and their siblings: a neurophysiological deficit in auditory sensory gating, diminished hippocampal volume, and increased catecholamine metabolism. Abnormal auditory sensory gating was found in all schizophrenics in the 11 families studied and in 8 of their 20 siblings. Compared with the schizophrenics, the clinically unaffected siblings with abnormal auditory gating had larger hippocampal volume. There was no similar difference for the siblings with normal gating. The siblings with abnormal auditory gating also had lower homovanillic acid levels than the other siblings. The data suggest that a familial neuronal deficit, identified by diminished sensory gating, may be a necessary, but not sufficient factor in the pathogenesis of schizophrenia. Individuals with this deficit are generally clinically unaffected, except for schizophrenics, who also have other abnormalities, such as diminished hippocampal volume and increased catecholamine metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043530     DOI: 10.1016/0920-9964(94)90067-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  21 in total

Review 1.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.

Authors:  David Potter; Ann Summerfelt; James Gold; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

2.  Advances in endophenotyping schizophrenia.

Authors:  David L Braff; Tiffany A Greenwood; Neal R Swerdlow; Gregory A Light; Nicholas J Schork
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

3.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

Authors:  R Freedman; H Coon; M Myles-Worsley; A Orr-Urtreger; A Olincy; A Davis; M Polymeropoulos; J Holik; J Hopkins; M Hoff; J Rosenthal; M C Waldo; F Reimherr; P Wender; J Yaw; D A Young; C R Breese; C Adams; D Patterson; L E Adler; L Kruglyak; S Leonard; W Byerley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 4.  Raising attention to attention deficit hyperactivity disorder in schizophrenia.

Authors:  Stefano Pallanti; Luana Salerno
Journal:  World J Psychiatry       Date:  2015-03-22

5.  P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.

Authors:  Bruce I Turetsky; Gersham Dent; Judith Jaeger; Stephen R Zukin
Journal:  Psychopharmacology (Berl)       Date:  2011-11-03       Impact factor: 4.530

6.  Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer).

Authors:  Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2014-02-20       Impact factor: 9.306

7.  Schizophrenia diagnosis and anterior hippocampal volume make separate contributions to sensory gating.

Authors:  Robert J Thoma; Faith M Hanlon; Helen Petropoulos; Gregory A Miller; Sandra N Moses; Ashley Smith; Lauren Parks; S Laura Lundy; Natalie M Sanchez; Aaron Jones; Mingxiong Huang; Michael P Weisend; Jose M Cañive
Journal:  Psychophysiology       Date:  2008-09-24       Impact factor: 4.016

8.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 9.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

Review 10.  Some methodological issues in neuroradiological research in psychiatry.

Authors:  T Becker; W Retz; E Hofmann; G Becker; E Teichmann; W Gsell
Journal:  J Neural Transm Gen Sect       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.